Ascendis Pharma A/S (ASND)

217.32 +2.27 (+1.06%) USD  |  NASDAQ  |  Jan 14, 16:00
217.42 +0.10 (+0.04%) After-Hours: 20:00
More

Ascendis Pharma Rent and Landing Expense (Quarterly)

Rent and Landing Expense (Quarterly) Chart

View Rent and Landing Expense (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Rent and Landing Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Rent and Landing Expense (Quarterly) Range, Past 5 Years

View Rent and Landing Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Rent and Landing Expense (Quarterly) Benchmarks

View Rent and Landing Expense (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S --
Evaxion AS --
DBV Technologies SA Upgrade
Cellectis SA --
Biodexa Pharmaceuticals Plc --